Infectious Disease Clinical Trials
A Phase 3 Multicenter, Randomized, Open-label, Clinical Trial of Telavancin
Versus Standard Intravenous Therapy in the Treatment of Subjects with
Staphylococcus aureus Bacteremia Including Infective Endocarditis
This study compares the antibiotic telavancin to standard antibiotic therapy
for the treatment of blood infections caused by S. aureus, including S.
aureus right-sided infective endocarditis.
Principal Investigator: Vasudev Tati, M.D.
Status: Currently recruiting participants.
Click here for additional information about this clinical trial.